1.55
Synlogic Inc stock is traded at $1.55, with a volume of 14,071.
It is down -7.74% in the last 24 hours and down -2.52% over the past month.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
See More
Previous Close:
$1.68
Open:
$1.7
24h Volume:
14,071
Relative Volume:
0.28
Market Cap:
$18.13M
Revenue:
$3.37M
Net Income/Loss:
$-57.28M
P/E Ratio:
-0.1442
EPS:
-10.7522
Net Cash Flow:
$-51.83M
1W Performance:
-7.38%
1M Performance:
-2.52%
6M Performance:
+51.22%
1Y Performance:
+10.71%
Synlogic Inc Stock (SYBX) Company Profile
Name
Synlogic Inc
Sector
Industry
Phone
617-659-2802
Address
PO BOX 30, WINCHESTER, MA
Compare SYBX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SYBX
Synlogic Inc
|
1.55 | 19.65M | 3.37M | -57.28M | -51.83M | -10.75 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-24-21 | Upgrade | Oppenheimer | Perform → Outperform |
Aug-21-19 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-30-19 | Initiated | Jefferies | Buy |
Dec-13-18 | Initiated | Chardan Capital Markets | Buy |
Mar-19-18 | Initiated | H.C. Wainwright | Buy |
Jan-29-18 | Initiated | Piper Jaffray | Overweight |
View All
Synlogic Inc Stock (SYBX) Latest News
Is Synlogic Inc. stock entering bullish territoryInsider Buying & High Conviction Investment Ideas - newser.com
Is Synlogic Inc. trending in predictive chart modelsMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
Can machine learning forecast Synlogic Inc. recoveryMarket Growth Summary & Daily Risk Controlled Trade Plans - newser.com
Volatility clustering patterns for Synlogic Inc.July 2025 Review & Daily Technical Forecast Reports - newser.com
Institutional scanner results for Synlogic Inc.Weekly Trend Summary & Long-Term Capital Growth Ideas - newser.com
Synlogic Inc. recovery potential after sell offWeekly Loss Report & Community Driven Trade Alerts - newser.com
Identifying reversal signals in Synlogic Inc.Market Rally & Expert-Curated Trade Recommendations - newser.com
Using RSI to spot recovery in Synlogic Inc.Weekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Order flow analysis tools used on Synlogic Inc.July 2025 News Drivers & High Accuracy Investment Signals - newser.com
Synlogic’s (SYBX) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
When is the best time to exit Synlogic Inc.July 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
Forecasting Synlogic Inc. price range with options dataQuarterly Trade Report & Precise Buy Zone Tips - newser.com
Synlogic Inc Stock Analysis and ForecastFundamental Stock Analysis & Big Returns Low Cost - earlytimes.in
Synlogic Inc. stock trend outlook and recovery pathWeekly Trade Recap & High Return Trade Guides - newser.com
Can Synlogic Inc. rally from current levelsJuly 2025 Summary & Community Verified Swing Trade Signals - newser.com
Synlogic Inc. stock chart pattern explainedEarnings Beat & Low Drawdown Investment Strategies - newser.com
What’s the recovery path for long term holders of Synlogic Inc.Earnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Trend analysis for Synlogic Inc. this weekInsider Selling & Weekly Top Gainers Trade List - newser.com
Price action breakdown for Synlogic Inc.Gold Moves & AI Forecast Swing Trade Picks - newser.com
Can technical indicators confirm Synlogic Inc.’s reversalJuly 2025 Review & High Conviction Investment Ideas - newser.com
Why institutional investors increase stakes in The Vita Coco Company Inc. (85E) stockWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Synlogic Inc Stock (SYBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Synlogic Inc Stock (SYBX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Dooley Mary Beth | See Remarks below |
Feb 03 '25 |
Sale |
1.33 |
2,107 |
2,802 |
13,045 |
Dooley Mary Beth | Head of Finance |
Oct 29 '24 |
Sale |
1.40 |
79 |
111 |
15,152 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):